𝐏𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐥𝐢𝐯𝐢𝐧𝐠 𝐰𝐢𝐭𝐡 𝐩𝐨𝐬𝐭-𝐚𝐜𝐮𝐭𝐞 𝐬𝐞𝐪𝐮𝐞𝐥𝐚𝐞 𝐨𝐟  𝐒𝐀𝐑𝐒-𝐂𝐨𝐕-𝟐 𝐢𝐧𝐟𝐞𝐜𝐭𝐢𝐨𝐧 (𝐏𝐀𝐒𝐂), 𝐀𝐊𝐀 𝐥𝐨𝐧𝐠 𝐂𝐎𝐕𝐈𝐃, 𝐥𝐢𝐯𝐞 𝐰𝐢𝐭𝐡 𝐚 𝐰𝐢𝐝𝐞 𝐚𝐫𝐫𝐚𝐲 𝐨𝐟 𝐬𝐲𝐦𝐩𝐭𝐨𝐦𝐬, 𝐫𝐚𝐧𝐠𝐢𝐧𝐠 𝐟𝐫𝐨𝐦 𝐦𝐢𝐥𝐝 𝐭𝐨 𝐬𝐞𝐯𝐞𝐫𝐞𝐥𝐲 𝐝𝐞𝐛𝐢𝐥𝐢𝐭𝐚𝐭𝐢𝐧𝐠.

🎙️🎙️🎙️ 𝐖𝐞 𝐬𝐢𝐭 𝐝𝐨𝐰𝐧 𝐰𝐢𝐭𝐡 𝟐 𝐥𝐞𝐚𝐝𝐢𝐧𝐠 𝐞𝐱𝐩𝐞𝐫𝐭𝐬, 𝐃𝐫.𝐀𝐧𝐠𝐞𝐥𝐚 𝐂𝐡𝐞𝐮𝐧𝐠 𝐚𝐧𝐝 𝐃𝐫.𝐙𝐚𝐢𝐧 𝐂𝐡𝐚𝐠𝐥𝐚, 𝐭𝐨 𝐬𝐞𝐞𝐤 𝐬𝐨𝐦𝐞 𝐜𝐥𝐚𝐫𝐢𝐭𝐲 𝐚𝐛𝐨𝐮𝐭 𝐥𝐨𝐧𝐠 𝐂𝐎𝐕𝐈𝐃’𝐬 𝐞𝐟𝐟𝐞𝐜𝐭𝐬, 𝐩𝐨𝐭𝐞𝐧𝐭𝐢𝐚𝐥 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭𝐬, 𝐬𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠, 𝐚𝐧𝐝 𝐡𝐨𝐰 𝐭𝐡𝐞 𝐝𝐢𝐬𝐞𝐚𝐬𝐞 𝐦𝐢𝐠𝐡𝐭 𝐢𝐦𝐩𝐚𝐜𝐭 𝐂𝐚𝐧𝐚𝐝𝐚’𝐬 𝐡𝐞𝐚𝐥𝐭𝐡 𝐜𝐚𝐫𝐞 𝐬𝐲𝐬𝐭𝐞𝐦 𝐢𝐧 𝐭𝐡𝐞 𝐟𝐮𝐭𝐮𝐫𝐞.

💡 💡 💡 𝙒𝙝𝙖𝙩 𝙘𝙖𝙣 𝙗𝙚 𝙙𝙤𝙣𝙚 𝙩𝙤 𝙝𝙚𝙡𝙥 𝙮𝙤𝙪𝙧 𝙥𝙖𝙩𝙞𝙚𝙣𝙩𝙨 𝙬𝙞𝙩𝙝 𝙡𝙤𝙣𝙜 𝘾𝙊𝙑𝙄𝘿?

💡 💡 𝘿𝙤𝙚𝙨 𝙗𝙚𝙞𝙣𝙜 𝙛𝙪𝙡𝙡𝙮 𝙫𝙖𝙘𝙘𝙞𝙣𝙖𝙩𝙚𝙙 𝙤𝙧 𝙗𝙤𝙤𝙨𝙩𝙚𝙙 𝙢𝙞𝙩𝙞𝙜𝙖𝙩𝙚 𝙩𝙝𝙚 𝙧𝙞𝙨𝙠 𝙤𝙛 𝙘𝙤𝙣𝙩𝙧𝙖𝙘𝙩𝙞𝙣𝙜 𝙇𝙊𝙉𝙂 𝘾𝙊𝙑𝙄𝘿 𝙤𝙧 𝙢𝙞𝙩𝙞𝙜𝙖𝙩𝙚 𝙩𝙝𝙚 𝙨𝙚𝙦𝙪𝙚𝙡𝙖𝙚 𝙤𝙛 𝙞𝙩? 𝘿𝙤𝙚𝙨 𝙩𝙝𝙚 𝙧𝙚𝙘𝙚𝙣𝙘𝙮 𝙤𝙛 𝙮𝙤𝙪𝙧 𝘾𝙊𝙑𝙄𝘿 𝙗𝙤𝙤𝙨𝙩𝙚𝙧 𝙤𝙧 𝙫𝙖𝙘𝙘𝙞𝙣𝙖𝙩𝙞𝙤𝙣 𝙖𝙡𝙨𝙤 𝙥𝙡𝙖𝙮 𝙖 𝙧𝙤𝙡𝙚?  

💡  𝙃𝙤𝙬 𝙨𝙝𝙤𝙪𝙡𝙙 𝙬𝙚 𝙗𝙚 𝙩𝙝𝙞𝙣𝙠𝙞𝙣𝙜 𝙖𝙗𝙤𝙪𝙩 𝙘𝙤𝙢𝙢𝙪𝙣𝙞𝙘𝙖𝙩𝙞𝙣𝙜 𝙩𝙝𝙚 𝙘𝙤𝙣𝙘𝙚𝙥𝙩 𝙤𝙛 𝙧𝙞𝙨𝙠, 𝙖𝙣𝙙 𝙛𝙧𝙖𝙢𝙞𝙣𝙜 𝙧𝙞𝙨𝙠 𝙩𝙤 𝙤𝙪𝙧 𝙥𝙖𝙩𝙞𝙚𝙣𝙩𝙨 𝙞𝙣 𝙩𝙝𝙚 𝙘𝙤𝙣𝙩𝙚𝙭𝙩 𝙤𝙛 𝙡𝙤𝙣𝙜 𝘾𝙊𝙑𝙄𝘿?

Dr. Angela Cheung

Dr. Angela Cheung is the KY and Betty Ho Chair of Integrative Medicine at the University of Toronto and is a professor of medicine and internal medicine specialist, as well as a senior scientist at the University Health Network in Toronto. Dr.Cheung holds a Tier 1 Canada Research Chair and She obtained her M.D. degree from Johns Hopkins University School of Medicine, and her Ph.D. degree from Harvard University. 

Dr.Cheung is the co-lead of CANCOV (Canadian COVID-19 Prospective Cohort Study) as well as RECLAIM (REcovering from COVID‑19 Lingering symptoms Adaptive Integrative Medicine) trial, a Canada-wide, open-label, pragmatic, adaptive randomized clinical trial platform to assess the effectiveness of various interventions in patients with lingering symptoms of COVID‑19.

Dr. Zain Chagla

Dr.Zain  Chagla, MD MSc MD, FRCPC  is an associate professor at McMaster University, co-medical director of infection control at St. Joseph’s Healthcare Hamilton and a consultant in infection control at Woodstock General Hospital. Dr. Chagla is also a teacher at McMaster University where he won a clinician teaching award in internal medicine and a young investigator grant for his work in supporting undergraduate medical education at the University of Namibia. 

Dr. Chagla also has a Master of Science in infectious diseases and a diploma in tropical medicine and hygiene from the London School of Hygiene & Tropical Medicine. 

As an infectious disease specialist, Dr.Zain Chagla has given media interviews on the COVID-19 pandemic and published several op-eds on testing, disease elimination, and public health interventions. He  has contributed to local, provincial, and federal policy planning, and to several clinical trials on COVID-19 therapies. He has published works on COVID-19 research, epidemiology, testing, and infection control. He is involved with a  prospective cohort study looking at respiratory physiology and radiologic features of patients post covid with persistent symptoms over time, including those with long covid and those who were critically ill.

Resources to further explore:

• The Canadian COVID-19 Prospective Cohort Study (CANCOV) 
• RECLAIM (REcovering from COVID‑19 Lingering symptoms Adaptive Integrative Medicine) trial
• Lancet: Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2